Characteristics and Potential of KSL, KSL-W, and Dadapin-1 Antimicrobial Peptides for Preventing Infections of Orthopedic Prosthetic Devices: Identifying the Most Robust Candidate
Authors:
- Davide CampocciaDCDavide Campoccia
- Andrea De DonnoADAndrea De Donno
- Giulia BottauGBGiulia Bottau
- Gloria BuaGBGloria Bua
- Stefano RavaioliStefano Ravaioli
- Eleonora CapponiECEleonora Capponi
- Giovanna SotgiuGSGiovanna Sotgiu
- Francesco PegreffiFrancesco Pegreffi
- Silvia CostantiniSCSilvia Costantini
- Carla Renata ArciolaCarla Renata Arciola
Open Access
- 11 August 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7745
Abstract
Antimicrobial peptides (AMPs) are increasingly emerging as alternatives to conventional antibiotics. This study compared the antibacterial activity of two decapeptides, KSL and KSL-W, and a 23-residue peptide, Dadapin-1, against bacterial species that colonize orthopedic implants, with the aim of identifying the most effective peptide for future AMP-based anti-infective orthopedic biomaterials. Staphylococcus aureus ATCC 25923 was the reference strain. The minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum biofilm inhibitory concentration (MBIC) of the AMPs were determined in both undiluted and diluted Mueller–Hinton Broth II (MHB II) to gain a simplified perspective on the potential interference of bioenvironments. The MBICs of the AMPs were close to their MICs. In diluted broth, a concentration of 3.91 μg/mL of KSL or KSL-W was bactericidal against staphylococci and prevented biofilm formation. An eight-fold higher concentration of Dadapin-1 was required to achieve bactericidal activity. Undiluted MHB II significantly hindered the antibacterial activity of KSL and Dadapin-1, while KSL-W was notably less affected. The values of LoA, a newly developed indicator of loss of activity, confirmed these findings. Bacterial species and strain influenced LoA. Furthermore, KSL-W exhibited a protective effect on osteoblasts co-cultured with S. aureus ATCC 25923. Overall, KSL-W emerged as the most promising candidate for AMP-based anti-infective orthopedic biomaterials.Keywords
Funding Information
- Postgraduate Medical School of Clinical Pathology and Clinical Biochemistry, University of Bologna (BUS25Q7_patobioclinica–bus25)
This publication has 48 references indexed in Scilit:
- Novel-designed antimicrobial peptides with dual antimicrobial and anti-inflammatory actions against Cutibacterium acnes for acne vulgaris therapyBiochemical Pharmacology, 2024
- Association of idealized amphiphiles and protease inhibitors: Conferring antimicrobial peptides with stable antibacterial activity under physiological conditions to combat multidrug-resistant bacteriaDrug Resistance Updates, 2024
- Combined Phase 1/2a Initial Clinical Safety Trials and Proof‐of‐Concept Assessment of a Novel Antimicrobial Peptide KSL‐W Anti‐Plaque Chewing GumClinical and Experimental Dental Research, 2024
- Peptide lipidation and shortening optimises antibacterial, antibiofilm and membranolytic actions of an amphiphilic polylysine-polyphenyalanine octapeptideCurrent Research in Biotechnology, 2024
- Encapsulation in oleyl-modified hyaluronic acid nanogels substantially improves the clinical potential of the antimicrobial peptides SAAP-148 and Ab-CathEuropean Journal of Pharmaceutics and Biopharmaceutics, 2023
- Advances of Antimicrobial Peptide‐Based Biomaterials for the Treatment of Bacterial InfectionsAdvanced Science, 2023
- Four‐day plaque regrowth evaluation of a peptide chewing gum in a double‐blind randomized clinical trialClinical and Experimental Dental Research, 2019
- Selection and redesign for high selectivity of membrane-active antimicrobial peptides from a dedicated sequence/function databaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 2019
- A review of the biomaterials technologies for infection-resistant surfacesBiomaterials, 2013
- Stability of Antimicrobial Decapeptide (KSL) and Its Analogues for Delivery in the Oral CavityPharmaceutical Research, 2007